Alqenae, Fatema A. http://orcid.org/0000-0001-9714-0007
Steinke, Douglas http://orcid.org/0000-0001-8917-2674
Belither, Hilary
Robertson, Peter
Bartlett, Jennifer
Wilkinson, Jack
Williams, Steven D. http://orcid.org/0000-0001-9080-5897
Brad, Lawrence
Jeffries, Mark http://orcid.org/0000-0002-6882-0350
Ashcroft, Darren M. http://orcid.org/0000-0002-2958-915X
Keers, Richard N. http://orcid.org/0000-0001-7854-8154
Article History
Accepted: 31 July 2023
First Online: 11 October 2023
Declarations
:
: This study was part of Fatema Alqenae’s Ph.D. programme at the University of Manchester funded by the Kuwait Civil Service Commission. Funding to pay for Open Access publication charges for this article was provided by the Kuwait Civil Service Commission. The interpretation and the conclusion in this study are the author’s view, and the funders had no role in the study design, data analysis or writing of the paper. The study evaluated the TCAM service, which is already funded in collaboration with the regional Academic Health Science Network and the Local Pharmaceutical Committee.
: Fatema A. Alqenae, Douglas Steinke, Peter Robertson, Hilary Belither, Jennifer Bartlett, Jack Wilkinson, Steven D. Williams, Lawrence Brad, Mark Jeffries, Darren M. Ashcroft and Richard N. Keers have declared no conflicts of interest in undertaking the proposed research.
: The research was exempt from the University Research Ethics Committee review as a decision by the University of Manchester University Research Ethics Committee (2019-7048-10983). Health Research Authority (IRAS project ID 262688) and host organisation (Research & Development—Capacity and Capability, and data sharing agreement with each primary care site) approvals were obtained before the start of the study.
: Not applicable.
: Not applicable.
: The datasets for this article are not publicly available as this was not approved by the Health Research Authority.
: Not applicable.
: All authors contributed to the study conception and design. Data cleaning, and coding and analysis were performed by FAA, supported by RNK, DS and HB. Data analysis was performed by FAA, supervised by JW, RNK and DS. The first draft of the manuscript was written by FAA, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Study guarantor/data custodian/chief investigator: RNK. Project administration: FAA. Conceptualised and study design: FAA, DS, RNK, HB, PR, JB, JW, MJ, DMA. Drafting data collection form: FAA, DS, RNK. Piloting data collection forms and feedback: PR. Training session material preparation: FAA, DS, RNK, HB, PR. Leading training sessions: FAA. Data entry: FAA. Data curation: primary data coding and screening: FAA. Supporting data coding: DS, RNK, HB. Formal data analysis: FAA. Data analysis supervision: DS, RNK, JW. Supervision: DS, RNK. Expert panel meeting (adverse drug event assessment): HB, SDW, LB. Data validation (medication discrepancy assessment): DS, RNK. Data visualisation: FAA. Interpretation of results: FAA, DS, RNK, HB, JB, JW. Writing original manuscript draft: FAA. Writing: review and editing manuscript: FAA, DS, RNK, HB, PR, JB, JW, MJ, DMA, SDW, LB. Approved final manuscript as submitted: FAA, DS, RNK, HB, PR, JB, JW, MJ, DMA, SDW, LB.